Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Iovance Biotherapeutics Inc (NQ: IOVA ) 9.760 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Oct 2, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Iovance Biotherapeutics Inc < Previous 1 2 3 4 5 6 7 8 9 ... 12 13 Next > How Is The Market Feeling About Iovance Biotherapeutics? July 22, 2024 Via Benzinga Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) July 19, 2024 From Iovance Biotherapeutics, Inc. Via GlobeNewswire 7 ‘Death Cross’ Stocks That Could Be Contrarian Buys July 17, 2024 Although death cross stocks sound incredibly ominous, they could be the ideal time to consider a contrarian position. Via InvestorPlace Is Iovance Biotherapeutics a Millionaire Maker? July 14, 2024 This biotech's future is bright, but how good could it get for investors? Via The Motley Fool 3 Under-$10 Biotech Stocks That Could Make You Rich July 11, 2024 Discover three under-$10 biotech stocks with potential to make you rich with huge returns on investment through an in-depth analysis. Via InvestorPlace What's Going On With Iovance Biotherapeutics Today? May 24, 2024 On Thursday, Iovance revealed updated clinical findings for lifileucel in conjunction with pembrolizumab as a treatment for frontline advanced melanoma, as well as implementation data, to be presented... Via Benzinga Iovance Biotherapeutics's Options: A Look at What the Big Money is Thinking May 10, 2024 Via Benzinga How Is The Market Feeling About Iovance Biotherapeutics? May 09, 2024 Via Benzinga Methode Electronics Posts Strong Sales, Joins QuantumScape, Ribbon Communications And Other Big Stocks Moving Higher On Thursday July 11, 2024 Via Benzinga Iovance Biotherapeutics Submits Marketing Authorization Application to European Medicines Agency for Lifileucel in Advanced Melanoma June 28, 2024 From Iovance Biotherapeutics, Inc. Via GlobeNewswire Is It Too Late to Buy Iovance Biotherapeutics Stock? June 28, 2024 The stock is down more than 50% from its 52-week high. Via The Motley Fool Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) June 21, 2024 From Iovance Biotherapeutics, Inc. Via GlobeNewswire 3 Top Penny Stocks to Skyrocket Your Wealth in 2024 June 21, 2024 Find out about the top penny stocks to buy this year for a chance to see incredible results down the road as they soar to new heights. Via InvestorPlace The Case for Buying Iovance Biotherapeutics Stock Just Got Even Better. Here's Why June 10, 2024 New data indicate that its cell therapy could soon find a larger market. Via The Motley Fool Oncotelic Therapeutics (OTC: OTLC) Inks Deal With Mosaic ImmunoEngineering To Sell Clinical-Stage Necroptosis Cancer Therapy Assets May 29, 2024 Oncotelic Therapeutics (OTC: OTLC) Inks Deal With Mosaic ImmunoEngineering To Sell Clinical-Stage Necroptosis Cancer Therapy Assets Via News Direct Exposures Product Safety Iovance Biotherapeutics to Present at Upcoming Conferences and Events May 24, 2024 From Iovance Biotherapeutics, Inc. Via GlobeNewswire 10 Health Care Stocks With Whale Alerts In Today's Session May 24, 2024 Via Benzinga Iovance Biotherapeutics Announces Clinical Data in Frontline Advanced Melanoma at ASCO 2024 Annual Meeting May 23, 2024 From Iovance Biotherapeutics, Inc. Via GlobeNewswire Bull Market Buys: 2 Growth Stocks to Own for the Long Run May 22, 2024 These biotech stocks have just launched their first products. Via The Motley Fool Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) May 17, 2024 From Iovance Biotherapeutics, Inc. Via GlobeNewswire 4 Small-Cap Value Stocks That Could Go Parabolic May 16, 2024 These four small-cap stocks scan as deeply undervalued right now. Via The Motley Fool The 3 Most Undervalued Biotech Stocks to Buy in May 2024 May 11, 2024 Three most undervalued biotech stocks to buy now will take off in the coming years and bring back continuous, hefty returns. Via InvestorPlace Why Iovance Stock Is Down 18% Today May 10, 2024 Investors are misunderstanding when the biopharma company's flagship drug will begin generating meaningful reportable revenue. Via The Motley Fool 12 Health Care Stocks Moving In Friday's Intraday Session May 10, 2024 Via Benzinga IOVA Stock Earnings: Iovance Biotherapeutics Meets EPS, Misses Revenue for Q1 2024 May 09, 2024 IOVA stock results show that Iovance Biotherapeutics met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. Via InvestorPlace Iovance Biotherapeutics Reports First Quarter 2024 Financial Results and Corporate Updates May 09, 2024 From Iovance Biotherapeutics, Inc. Via GlobeNewswire Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session May 10, 2024 Via Benzinga Got $500? These Hot Growth Stocks Are Screaming Buys Right Now May 05, 2024 The time to jump into a red-hot growth prospect is usually right now...before any more investors identify the opportunity. Via The Motley Fool Iovance Biotherapeutics to Host First Quarter 2024 Financial Results Conference Call and Webcast on Thursday, May 9, 2024 May 01, 2024 From Iovance Biotherapeutics, Inc. Via GlobeNewswire Iovance Biotherapeutics to Present at Upcoming Conferences April 30, 2024 From Iovance Biotherapeutics, Inc. Via GlobeNewswire < Previous 1 2 3 4 5 6 7 8 9 ... 12 13 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.